Results 71 to 80 of about 3,651 (163)

Risk Evaluation and Mitigation Strategies for Potential Outbreaks of Nipah Virus Infection: Evidenced by the Recent Incidences in Southeast Asian Countries

Health Science Reports, Volume 7, Issue 12, December 2024.
ABSTRACT Background The importance of studying Nipah virus (NiV) stems from its high fatality rates and potential for causing widespread outbreaks. Recent incidences in Southeast Asian countries highlight the urgent need for effective risk evaluation and mitigation strategies.
Md. Ashrafur Rahman, Yeasna Shanjana, Sydney Cronmiller, Donovan Zong, Rob Davis, Julianne Ernest, Jonah Nguyen, Amanda Rawa, Marie Roke Thomas, Md. Rabiul Islam   +9 more
wiley   +1 more source

A highly effective ferritin-based divalent nanoparticle vaccine shields Syrian hamsters against lethal Nipah virus

Frontiers in Immunology
The Nipah virus (NiV), a highly deadly bat-borne paramyxovirus, poses a substantial threat due to recurrent outbreaks in specific regions, causing severe respiratory and neurological diseases with high morbidity. Two distinct strains, NiV-Malaysia (NiV-M)
Chunhong Yin, Chunhong Yin, Yan Feng Yao, Yan Feng Yao, Peipei Yang, Peipei Yang, Hang Liu, Hang Liu, Ge Gao, Ge Gao, Yun Peng, Yun Peng, Miaoyu Chen, Miaoyu Chen, Mingqing Lu, Mingqing Lu, Xuekai Zhang, Xuekai Zhang, Weiwei Guo, Weiwei Guo, Zihan Zhang, Zihan Zhang, Xue Hu, Xue Hu, Zhiming Yuan, Zhiming Yuan, Chao Shan, Chao Shan, Chao Shan, Chao Shan   +29 more
doaj   +1 more source

A Functional Genomics Approach to Henipavirus Research: The Role of Nuclear Proteins, MicroRNAs and Immune Regulators in Infection and Disease [PDF]

, 2017
Hendra and Nipah viruses (family Paramyxoviridae, genus Henipavirus) are zoonotic RNA viruses that cause lethal disease in humans and are designated as Biosafety Level 4 (BSL4) agents. Moreover, henipaviruses belong to the same group of viruses that cause disease more commonly in humans such as measles, mumps and respiratory syncytial virus. Due to the
Stewart, CR, Deffrasnes, C, Foo, CH, Bean, AGD, Wang, L-F   +4 more
openaire   +3 more sources

Unravelling the mystery of Nipah virus: from virus to therapeutics: current insights and future frontiers

Bulletin of the National Research Centre
Background Nipah virus (NiV) is a high-risk zoonotic infection that results in severe respiratory and neurological disease, with case fatality rates typically exceeding 70%. Driven by reservoir-host spillover and intermittent human-to-human transmission,
Jignesh Bhate, Rakesh Jain, Arun Vivek Jayabalan   +2 more
doaj   +1 more source

Novel transcription and replication-competent virus-like particles system modelling the Nipah virus life cycle

Emerging Microbes and Infections
Nipah virus (NiV), a highly pathogenic Henipavirus in humans, has been responsible for annual outbreaks in recent years. Experiments involving live NiV are highly restricted to biosafety level 4 (BSL-4) laboratories, which impedes NiV research.
Yulong Wang, Linjin Fan, Pengfei Ye, Zequn Wang, Chudan Liang, Quan Liu, Xiaofeng Yang, Zhenyu Long, Wendi Shi, Yuandong Zhou, Jingyan Lin, Huijun Yan, Hongxin Huang, Linna Liu, Jun Qian   +14 more
doaj   +1 more source

Inhibition of henipavirus infection by Nipah virus attachment glycoprotein occurs without cell-surface downregulation of ephrin-B2 or ephrin-B3

Journal of General Virology, 2007
Nipah virus (NiV) and Hendra virus (HeV) are newly identified members of the family Paramyxoviridae and have been classified in the new genus Henipavirus based on unique genetic characteristics distinct from other paramyxoviruses.
Bevan, Sawatsky, Allen, Grolla, Nina, Kuzenko, Hana, Weingartl, Markus, Czub   +4 more
openaire   +2 more sources

Predicting the next pandemic: VACCELERATE ranking of the World Health Organization's Blueprint for Action to Prevent Epidemics

Travel Medicine and Infectious Disease
Introduction: The World Health Organization (WHO)'s Research and Development (R&D) Blueprint for Action to Prevent Epidemics, a plan of action, highlighted several infectious diseases as crucial targets for prevention.
Jon Salmanton-García, Pauline Wipfler, Janina Leckler, Pontus Nauclér, Patrick W. Mallon, Patricia C.J.L. Bruijning-Verhagen, Heinz-Joseph Schmitt, Ullrich Bethe, Ole F. Olesen, Fiona A. Stewart, Kerstin Albus, Oliver A. Cornely, Martin Busch, Ulrike Seifert, Andreas Widmer, Miki Nagao, Jordi Rello, Tatina Todorova, Sabina Cviljević, Christopher H. Heath, Ligita Jančorienė, Thea Koelsen Fischer, Hans Martin Orth, Isik Somuncu Johansen, Mehmet Doymaz, Athanasios Tragiannidis, Thomas Löscher, Jin-Fu Xu, Petr Husa, José Antonio Oteo, Mohammad I. Issack, Markus Zeitlinger, Roger Le Grand, Przemysław Zdziarski, Fatih Demirkan, Paloma Merino Amador, Tomás García-Lozano, Qing Cao, Lourdes Vázquez, Juan Pablo Caeiro, Peter Hermans, Shahroch Nahrwar, Korkut Avsar, Deepak Kumar, Norma Fernández, Masoud Mardani, Esther Segal, Angelo Pan, Despoina Gkentzi, Georgia Gioula, Jorge Alberto Cortés, Joaquim Oliveira, Pierre van Damme, Mohd Zaki Bin Mohd Zaili, Spinello Antinori, Birutė Zablockienė, Georgios Papazisis, Chioma Inyang Aneke, Maricela Valerio, Samuel McConkey, Avinash Aujayeb, Anna Maria Azzini, Jelena Roganović, Kristin Greve-Isdahl Mohn, Peter Kremsner, Effrossyni Gkrania-Klotsas, Dora Corzo, Nina Khanna, Tomasz Smiatacz, Simone Scheithauer, Maria Merelli, Boris Klempa, Radovan Vrḫovac, Antonio Ruggiero, Pankaj Chaudhary, Julio Maquera-Afaray, Miquel Ekkelenkamp, Pavel Jindra, Nikola Pantić, Gemma Jiménez Guerra, Guenter Weiss, Behrad Roohi, Christos D. Argyropoulos, Sven Aprne Silfverdal, Jens van Praet, Zumrut Sahbudak Bal, Souha Kanj, Barnaby Young, Zoi Dorothea Pana, Emmanuel Roilides, Stephen C. Stearns, Joost Wauters, Jesús Rodríguez Baño, Mathias W. Pletz, Maja Travar, Steven Kühn, Fernando Riera, Daniel Cornely, Vlad Jeni Laura, Philipp Koehler, Brian Eley, Pravin K. Nair, Sandra Ciesek, Ioana Diana Olaru, Laura Marques, Emanuele Pontali, Alexandra Naunheim, Adrian Lieb, Markus Gerhard, Joveria Qais Farooqi, Lance Turtle, Gustavo Adolfo Méndez, Rebecca Jane Cox, Nigel Goodman, Billie Caceca, Javier Pemán, Halima Dawood, Helena Hervius Askling, Anders Fomsgaard, Alejandra Calderón Hernández, Cornelia Staehelin, Chia-Ying Liu, Giancarlo Icardi, Elio Castagnola, Helmut J.F. Salzer, Jens Lundgren, Samir Javadli, Fabio Forghieri   +127 more
doaj   +1 more source

Abdominal Pain in Langya Henipavirus and Severity of Infection

Assam Journal of Internal Medicine, 2023
Pathum Sookaromdee, Viroj Wiwanitkit
openaire   +3 more sources

Development of a real-time RT-PCR assay for detection of Hendra and Nipah viruses

Инфекция и иммунитет
The article is devoted to the development of a method for detection of viral RNA of two highly pathogenic zoonotic viruses from the genus Henipavirus — Hendra and Nipah using real-time reverse transcription polymerase chain reaction.
Svetlana A. Shirobokova, Anna V. Shabalina, Igor S. Sukhikh, Vera A. Chayeb, Anna S. Dolgova, Vladimir G. Dedkov   +5 more
doaj   +1 more source

An in vivo BSL-2 model for henipavirus infection based on bioluminescence imaging of recombinant Cedar virus replication in mice

Frontiers in Chemical Biology
Henipaviruses are enveloped single-stranded, negative-sense RNA viruses of the paramyxovirus family. Two henipaviruses, Nipah virus and Hendra virus, cause a systemic respiratory and/or neurological disease in humans and ten additional species of mammals, with a high fatality rate. Because of their highly pathogenic nature, Nipah virus and Hendra virus
Celeste, Huaman, Caitlyn, Clouse, Madeline, Rader, Lianying, Yan, Shuangyi, Bai, Bronwyn M, Gunn, Moushimi, Amaya, Eric D, Laing, Christopher C, Broder, Brian C, Schaefer   +9 more
openaire   +2 more sources